nach oben

Erschienen in:

01.06.2013 | Original article

Postprostatectomy ultrasound-guided transrectal implantation of gold markers for external beam radiotherapy

Technique and complications rate

verfasst von: J.F. Langenhuijsen, M.D., Ph.D., R. Donker, M.D., G.M. McColl, M.Sc., L.A.L.M. Kiemeney, Ph.D., J.A. Witjes, M.D., Ph.D., E.N.J.T. van Lin, M.D., Ph.D

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

Postprostatectomy radiotherapy (RT) improves survival in adjuvant and salvage settings. The implantation technique and complications rate of gold markers in the prostate bed for high-precision RT were analyzed.

Patients and methods

Patients undergoing postprostatectomy RT for prostate-specific antigen (PSA) relapse or high-risk disease were enrolled in the study. Under transrectal ultrasound guidance, three fine gold markers were implanted in the prostate bed and the technical difficulties of insertion were documented. Patients received our self-designed questionnaires concerning complications and pain. The influence of anticoagulants and coumarins on bleeding was analyzed, as was the effect of potential risk factors on pain.

Results

In 77 consecutive patients, failure of marker implantation or marker migration was seen in six cases. Rectal bleeding was reported by 10 patients and 1 had voiding complaints. No macroscopic hematuria persisting for more than 3 days was observed. Other complications included rectal discomfort (n = 2), nausea (n = 1), abdominal discomfort (n = 1), and pain requiring analgesics (n = 4). No major complications were reported. On a 0–10 visual analogue scale (VAS), the mean pain score was 3.7. No clinically significant risk factors for complications were identified.

Conclusion

Transrectal implantation of gold markers in the prostate bed is feasible and safe. Alternatives like cone beam computed tomography (CBCT) should be considered, but the advantages of gold marker implantation for high-precision postprostatectomy RT would seem to outweigh the minor risks involved.

Wu J, Haycocks T, Alasti H et al (2001) Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocenter set-up verification and implanted prostate markers. Radiother Oncol 61:127–133PubMedCrossRef

Van den Heuvel F, Fugazzi J, Seppi E et al (2006) Clinical application of a repositioning scheme, using gold markers and portal imaging. Radiother Oncol 79:94–100CrossRef

Ghadjar P, Gwerder N, Madlung A et al (2009) Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer. Strahlenther Onkol 185:731–735PubMedCrossRef

Moman MR, Heide UA van der, Kotte ANTJ et al (2010) Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life. Radiother Oncol 96:38–42PubMedCrossRef

Langenhuijsen JF, Lin EN van, Kiemeney LA et al (2007) Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. Int J Radiat Oncol Biol Phys 69:671–676PubMedCrossRef

Peeters ST, Heemsbergen WD, Koper PC et al (2006) Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24:1990–1996PubMedCrossRef

Zietman AL, DeSilvio ML, Slater JD et al (2005) Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294:1233–1239PubMedCrossRef

Zelefsky MJ, Levin EJ, Hunt M et al (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:1124–1129PubMedCrossRef

Thompson IM, Tangen CM, Paradelo J et al (2009) Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial. J Urol 181:956–962PubMedCrossRef

10.

Stephenson AJ, Scardino PT, Kattan MW et al (2007) Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25:2035–2041PubMedCrossRef

11.

Cremers RG, Lin EN van, Gerrits WL et al (2010) Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy. Radiother Oncol 97:467–473PubMedCrossRef

12.

Bottke D, Bartkowiak D, Schrader M, Wiegel T (2012) Radiotherapy after radical prostatectomy: immediate or early delayed? Strahlenther Onkol 188:1096–1101PubMedCrossRef

13.

Langen KM, Jones DT (2001) Organ motion and its management. Int J Radiat Oncol Biol Phys 50:265–278PubMedCrossRef

14.

Bylund KC, Bayouth JE, Smith MC et al (2008) Analysis of interfraction prostate motion using megavoltage cone beam computed tomography. Int J Radiat Oncol Biol Phys 72:949–956PubMedCrossRef

15.

Frank SJ, Dong L, Kudchadker RJ et al (2008) Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71:813–820PubMedCrossRef

16.

Kupelian P, Willoughby T, Mahadevan A et al (2007) Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 67:1088–1098PubMedCrossRef

17.

Pinkawa M, Siluschek J, Gagel B et al (2007) Postoperative radiotherapy for prostate cancer: evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy). Strahlenther Onkol 183:23–29PubMedCrossRef

18.

Sandhu A, Sethi R, Rice R et al (2008) Prostate bed localization with image-guided approach using on-board imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomy. Radiother Oncol 88:20–25PubMedCrossRef

19.

Schiffner DC, Gottschalk AR, Lometti M et al (2007) Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys 67:610–619PubMedCrossRef

20.

Kupelian PA, Langen KM, Willoughby TR et al (2006) Daily variations in the position of the prostate bed in patients with prostate cancer receiving postoperative external beam radiation therapy. Int J Radiat Oncol Biol Phys 66:593–596PubMedCrossRef

21.

Yang J, Abdel-Wahab M, Ribeiro A (2011) EUS-guided fiducial placement after radical prostatectomy before targeted radiation therapy for prostate cancer recurrence. Gastrointest. Endosc 73:1302–1305

22.

Ost P, Meerleer G de, Gersem W de et al (2011) Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy. Int J Radiat Oncol Biol Phys 79:188–194PubMedCrossRef

23.

Dehnad H, Nederveen AJ, Heide UA van der et al (2003) Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother and Oncol 67:295–302CrossRef

24.

Henry AM, Wilkinson C, Wylie JP et al (2004) Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracy. Radiother Oncol 73:57–59PubMedCrossRef

25.

Surya B, Provet J, Johanson K et al (1990) Anastomotic strictures following radical prostatectomy: risk factors and management. J Urol 143:755–758PubMed

26.

Park R, Martin S, Goldberg JD, Lepor H (2001) Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence. Urology 57:742–746PubMedCrossRef

27.

Piziorska M, Kukolowicz P, Zawadzka A et al (2012) Adaptive off-line protocol for prostate external radiotherapy with cone beam computer tomography. Strahlenther Onkol 188:1003–1009PubMedCrossRef

Titel: Postprostatectomy ultrasound-guided transrectal implantation of gold markers for external beam radiotherapy
Technique and complications rate
verfasst von: J.F. Langenhuijsen, M.D., Ph.D.
R. Donker, M.D.
G.M. McColl, M.Sc.
L.A.L.M. Kiemeney, Ph.D.
J.A. Witjes, M.D., Ph.D.
E.N.J.T. van Lin, M.D., Ph.D
Publikationsdatum: 01.06.2013
Verlag: Springer-Verlag
Erschienen in: Strahlentherapie und Onkologie / Ausgabe 6/2013
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-013-0323-4

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Postprostatectomy ultrasound-guided transrectal implantation of gold markers for external beam radiotherapy

Technique and complications rate